Norges Bank Takes Position in DENTSPLY SIRONA Inc. $XRAY

Norges Bank acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 2,500,025 shares of the medical instruments supplier’s stock, valued at approximately $39,700,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brooklyn Investment Group acquired a new position in DENTSPLY SIRONA in the first quarter valued at about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at approximately $26,000. Trust Co. of Toledo NA OH acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $27,000. Parkside Financial Bank & Trust boosted its position in shares of DENTSPLY SIRONA by 620.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its holdings in DENTSPLY SIRONA by 8,003.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 2,241 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have commented on XRAY. Evercore ISI decreased their price target on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. UBS Group reduced their price target on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, October 28th. Finally, Barrington Research dropped their price objective on shares of DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Two investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $16.08.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $11.25 on Friday. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The company has a market cap of $2.24 billion, a price-to-earnings ratio of -2.55, a price-to-earnings-growth ratio of 0.82 and a beta of 1.01. The stock’s 50-day moving average is $11.90 and its two-hundred day moving average is $13.91. DENTSPLY SIRONA Inc. has a 1-year low of $9.85 and a 1-year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The company had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The business’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.